These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2429941)

  • 21. Prenatal serum alpha-fetoprotein screening for neural tube defects.
    Macri JN; Weiss RR
    Obstet Gynecol; 1982 May; 59(5):633-9. PubMed ID: 6175932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-Fetoprotein screening.
    Burton BK
    Adv Pediatr; 1986; 33():181-96. PubMed ID: 2432763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prenatal diagnosis. I: Prenatal diagnosis program at the Medical Genetics Unit of the Universidad de Zulia, Maracaibo, Venezuela].
    Prieto-Carrasquero M; Molero A; Carrasquero N; Paz V; González S; Pineda-Del Villar L; Del Villar A; Rojas-Atencio A; Quintero M; Fulcado W; Mena R; Morales-Machin A
    Invest Clin; 1998 Jun; 39(2):97-116. PubMed ID: 9707921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The centralized prenatal genetics screening program of New York City III: The first 7,000 cases.
    Benn PA; Hsu LY; Carlson A; Tannenbaum HL
    Am J Med Genet; 1985 Feb; 20(2):369-84. PubMed ID: 2579556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical screening of congenital developmental abnormalities using determination of fetoplacental antigens.
    Fialová L; Malbohan I; Mikulíková L; Hájek Z
    Acta Univ Carol Med (Praha); 1993; 39(1-4):3-8. PubMed ID: 9355657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis of neural tube defects.
    Dembert ML; Harisiades JP
    Am Fam Physician; 1983 Feb; 27(2):241-4. PubMed ID: 6187201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening model of studying alpha-foetoprotein of maternal serum (S-AFP) organized within central dispensary follow-up of pregnant women in Baranya region.
    Kóbor J; Pejtsik B; Pácsa S
    Sante Publique (Bucur); 1982; 25(3):193-9. PubMed ID: 6187074
    [No Abstract]   [Full Text] [Related]  

  • 30. When does mass screening for open neural tube defects in low-risk pregnancies result in cost savings?
    Tosi LL; Detsky AS; Roye DP; Morden ML
    CMAJ; 1987 Feb; 136(3):255-65. PubMed ID: 2433011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
    Campbell TL
    J Fam Pract; 1987 Nov; 25(5):461-7. PubMed ID: 2445897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
    Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
    AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal diagnosis of open neural tube defects using the amniotic fluid acetylcholinesterase assay.
    Milunsky A; Sapirstein VS
    Obstet Gynecol; 1982 Jan; 59(1):1-5. PubMed ID: 6176922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. With HIV prevalence among women increasing, more provinces encourage prenatal testing.
    Silversides A
    CMAJ; 1998 Jun; 158(11):1518-9. PubMed ID: 9629119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of a program for the prevention of neural tube defects].
    Kalmár Z; Czeizel E
    Orv Hetil; 1988 Jun; 129(23):1205-6, 1209-12. PubMed ID: 2453827
    [No Abstract]   [Full Text] [Related]  

  • 36. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
    Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
    J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What participants understand about a maternal serum alpha-fetoprotein screening program.
    Faden RR; Chwalow AJ; Orel-Crosby E; Holtzman NA; Chase GA; Leonard CO
    Am J Public Health; 1985 Dec; 75(12):1381-4. PubMed ID: 2415009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal diagnosis fo neural tube defects.
    Kolata GB
    Science; 1980 Sep; 209(4462):1216-8. PubMed ID: 6157193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.